Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01970488
Brief Title: Study to Compare Efficacy and Safety of ABP 501 and Adalimumab (HUMIRA®) in Adults With Moderate to Severe Plaque Psoriasis

First Submitted : October 23, 2013
First Submitted that Met QC Criteria : October 23, 2013
First Posted : October 28, 2013 (Estimate)

Results First Submitted : October 20, 2016
Results First Submitted that Met QC Criteria : October 20, 2016
Results First Posted : December 13, 2016 (Estimate)

Certification/Extension First Submitted : May 19, 2015
Certification/Extension First Submitted that Met QC Criteria : May 19, 2015
Certification/Extension First Posted : June 12, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : April 1, 2019
Last Update Posted : April 3, 2019